They compared two groups: patients taking GLP-1 medications and those not taking them
By emphasizing the usefulness of CGMS in monitoring blood glucose levels and assessing treatment adequacy, patients with type 1 diabetes can make informed decisions regarding insulin adjustments and overall diabetes control
Tirzepatide, a GLP-1/GIP dual agonist, has demonstrated mean body weight reductions of approximately 20.9% over 72 weeks in adults with obesity
Semaglutide helps with weight loss by decreasing appetite, achieved by slowing stomach emptying
Prevention during dose increases Dose escalation is a common trigger
Seems to work great with caffeine (I recommend green tea rather than coffee) I will use ALC forever :) I fill better on these then not on them, only been on them now for 2 weeks, I would re take them and see how much more I can shape up better